21.83
-0.17
(-0.75%)
At close: April 17 at 8:51:48 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AFEYAN NOUBAR BOGHOS Director | Sale | Jul 31, 2024 | 6,856,160 |
| BANCEL STEPHANE J Chief Executive Officer | Purchase | Mar 3, 2025 | -- |
| BERENSON STEPHEN A. Director | Conversion of Exercise of derivative security | May 3, 2024 | 22,203 |
| GARAY ARPA Officer | Sale | Dec 6, 2023 | 3,690 |
| HOGE STEPHEN President | Conversion of Exercise of derivative security | Feb 28, 2025 | 1,606,780 |
| HORNING SANDRA Director | Conversion of Exercise of derivative security | Apr 28, 2023 | 1,373 |
| KLINGER SHANNON THYME Officer | Conversion of Exercise of derivative security | Mar 7, 2025 | 25,612 |
| MOCK JAMES M Chief Financial Officer | Conversion of Exercise of derivative security | Apr 4, 2025 | 15,623 |
| NABEL ELIZABETH G Director | Conversion of Exercise of derivative security | May 3, 2024 | 2,105 |
| SAGAN PAUL L Director | Purchase | Mar 3, 2025 | -- |
Related Tickers
AYJ.F Valneva SE
3.0440
+0.46%
1JK.F Apellis Pharmaceuticals, Inc.
15.39
-2.87%
A71.F Ascendis Pharma A/S
140.00
+6.06%
GBY.MU Sangamo Therapeutics Inc
0.6266
-2.66%
PI3.F Gubra A/S
47.88
+0.21%
22UA.F BioNTech SE
86.05
+1.24%
FYB.DE Formycon AG
22.95
-1.71%
1VT.BE Viking Therapeutics Inc
20.68
+0.41%
MOLN.SW Molecular Partners AG
3.1600
-3.66%
MDG1.DE Medigene AG
0.1995
+15.32%